AA
PFE icon

Auxano Advisors’s Pfizer PFE Stock Holding History

Auxano Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
10,337
-45
-0.4% -$1.18K 0.05% 178
2026
Q1 		$292K Buy
10,382
+120
+1% +$3.19K 0.06% 159
2025
Q4 		$256K Sell
10,262
-52
-0.5% -$1.31K 0.05% 166
2025
Q3 		$263K Sell
10,314
-12,409
-55% -$306K 0.06% 149
2025
Q2 		$551K Sell
22,723
-761
-3% -$17.7K 0.13% 91
2025
Q1 		$595K Sell
23,484
-943
-4% -$24.7K 0.16% 86
2024
Q4 		$648K Buy
24,427
+3,553
+17% +$96.4K 0.16% 82
2024
Q3 		$604K Buy
20,874
+702
+3% +$20.5K 0.16% 93
2024
Q2 		$564K Sell
20,172
-135
-0.7% -$3.72K 0.16% 90
2024
Q1 		$564K Buy
+20,307
New +$563K 0.16% 89
2023
Q4 		– Sell
-7,636
Closed -$253K – 133
2023
Q3 		$253K Buy
7,636
+268
+4% +$9.48K 0.1% 87
2023
Q2 		$301K Hold
7,368
– – 0.12% 82
2023
Q1 		$301K Buy
7,368
+643
+10% +$27.8K 0.12% 82
2022
Q4 		$345K Buy
6,725
+8
+0.1% +$384 0.16% 73
2022
Q3 		$294K Buy
6,717
+1,883
+39% +$91.5K 0.14% 75
2022
Q2 		$253K Buy
4,834
+321
+7% +$16.4K 0.13% 67
2022
Q1 		$234K Buy
+4,513
New +$234K 0.1% 73

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Auxano Advisors's PFE Position: Q2 2026 in Review

Auxano Advisors reduced its Pfizer (PFE) stake by 0.43% in Q2 2026, selling an estimated $1.18K and leaving 10,337 shares worth $249K. The position accounts for 0.05% of the portfolio, ranked #178.

Auxano Advisors first reported a position in PFE in Q1 2022 and has held it in 17 quarters since. The position peaked at $648K in Q4 2024. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Auxano Advisors held 10,337 shares of Pfizer worth $249K as of Q2 2026.
  • Auxano Advisors sold 45 Pfizer shares in Q2 2026, an estimated $1.18K.
  • Pfizer made up 0.05% of Auxano Advisors's portfolio in Q2 2026, its #178 holding.
  • Auxano Advisors first reported a position in Pfizer in Q1 2022 and has held it in 17 quarters since.
  • Auxano Advisors's Pfizer position peaked at $648K in Q4 2024.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Auxano Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.